Camera showdown: which machine best sees heart failure damage?

NCT ID NCT02515812

Completed Knowledge-focused Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two types of cameras—a newer CZT camera and a standard Anger camera—to see how well they measure heart nerve function in people with heart failure. Forty-five patients received a special tracer injection (I-123-MIBG) and were scanned with both cameras. The goal was to validate whether the newer camera gives equally reliable results, which could help doctors better assess heart failure severity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: I-123-MIBG
What this could lead to: If successful, this could help doctors choose the best camera for evaluating heart failure patients, potentially improving risk assessment.
What could go wrong: This is a small, completed imaging comparison study, not a treatment trial. It does not test any new therapy or directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Médecine Nucléaire -CHU de Caen

Caen, 14000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.